Pipeline Café Participants
The pipeline café features academic innovators who are hand selected to present their discoveries, which are available for partnering, in two poster sessions. The academic innovators will be available for discussions at their posters as well as one-on-one partnering meetings.
Darnisha Harrison, Founder & CEO, Ennaid Therapeutics – Using Flavivirus Peptide Inhibitors To Treat All Four Strains of Dengue Virus
Gerard Honig, PhD, Founder & Chief Executive Officer, Symbiotic Health, Inc. – Effectiveness of a microbiome-based capsule therapeutic for the treatment of recurrent C. difficile infection
Jingfang Ju, Ph.D, Co-Director of Translational Research Laboratory, Department of Pathology, Stony Brook University – Overcome Chemoresistance via miRNA in Colorectal Cancer
Sanjoy K. Mahanty, PhD, Chief Executive Officer, MirCan Therapeutics, LLC – Development of miR-708, a unique regulatory micro RNA molecule for the treatment of metastatic breast cancer including triple negative breast cancer (TNBC)
Maria Pineda, PhD, CEO and Martin Akerman, PhD, CSO, Envisagenics – The SpliceCoreTM platform: Uncovering hidden patterns in biological data to advance drug-development
Mark Punyanitya, Co-Founder, MagnePath USA – Improving Quantitative Imaging for Obesity, Diabetes, and Liver Disease
John P. Wilson, PhD, Chief Executive Officer, Banish Technologies™
Banish Technologies™: eliminate bacteria reservoir biohazards
Nader Yaghoubi, MD, PhD, President and Chief Executive Officer, PathMaker NeuroSystems Inc.- Non-Invasive Neuromodulation using trans-spinal Direct Current Stimulation (tsDCS) for the treatment of Paralysis and Muscle Disorders
Weng-Lang Yang, PhD, Chief Scientific Officer, Therasource – Recombinant Human MFG-E8 Protein for Treating Inflammatory Diseases
Ehsan Yazdi, PhD, Chief Executive Officer, NomoCan Pharmaceuticals LLC – A Novel Drug for Diagnosis and Treatment of Pancreatic Cancer